FDA Grants Expanded Approval to Skyrizi for Ulcerative Colitis On June 18th, the U.S. Food and Drug Administration (FDA) approved AbbVie’s...
Vous n'êtes pas connecté
Abbott has received clearance from the Food and Drug Administration in the USA for an over-the-counter (OTC) glucose monitor. The device, called Lingo, first debuted in the U.K. last year as a sensor for people who do not have diabetes to track glucose spikes. Abbott now hopes to bring it to the U.S. and, with […]
FDA Grants Expanded Approval to Skyrizi for Ulcerative Colitis On June 18th, the U.S. Food and Drug Administration (FDA) approved AbbVie’s...
Biotech Botanix says it has received firm commitments to raise $70 million from institutional investors just a day after it received US Food and Drug...
NORTH CHICAGO, Ill., June 25, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced it received a Complete Response Letter (CRL) from the U.S. Food...
The U.S. Food and Drug Administration (FDA) has expanded orphan drug designation for SurVaxM, a brain cancer immunotherapy born in the labs of Roswell...
The Vietnam Association of Diabetes and Endocrinology introduced the first continuous glucose monitoring protocol guideline to healthcare...
July 2 - The U.S. Food and Drug Administration on Tuesday gave a green light to Eli Lilly's LLY.N donanemab for patients with early Alzheimer's,...
FRIDAY, June 21, 2024 -- The U.S. Food and Drug Administration has expanded indications for Rinvoq (upadacitinib) to now include pediatric patients...
Pharmaceutical and healthcare company Unilab Inc. lauded the Food and Drug Administration (FDA) for taking proactive measures to protect the public...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun. 20, 2024-- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare...
Results from a new study show the impact and importance of continuous glucose monitoring (CGM) that young individuals with diabetes face today. The...